Condition: Non-small Cell Lung Cancer · Melanoma · Renal Cell Carcinoma · Sponsor: Shanghai Henlius Biotech
This is a multicenter, randomized, double-blind, parallel-controlled phase I clinical study to evaluate the similarity in PK profile, efficacy, safety, and immunogenicity of HLX17 vs. US-sourced Keytruda® in patients with resected non-small cell lung cancer (NSCLC) or melanoma (MEL), or renal cell carcinoma (RCC).
This description comes directly from the study's public registry record.
Lin Wu, MD · 13170419973 · wulin-calf@vip.163.com
Always discuss trial participation with your own doctor first.
| Oncology Physicians Network (OPN) - Glendale | Glendale, California, United States | Recruiting |
| Oncology Physicians Network (OPN)- Los Alamitos | Los Alamitos, California, United States | Recruiting |
| HCA | Los Angeles, California, United States | Not Yet Recruiting |
| Los Angeles Cancer Network | Los Angeles, California, United States | Not Yet Recruiting |
| Oncology Physicians Network (OPN) - San Bernardino | San Bernardino, California, United States | Recruiting |
| BRCR Global | Deerfield Beach, Florida, United States | Not Yet Recruiting |
| D&H National Research Center | Margate, Florida, United States | Recruiting |
| Ocala Oncology | Ocala, Florida, United States | Not Yet Recruiting |
| Mid Florida Hematology and oncology Center | Orange City, Florida, United States | Recruiting |
| Oncology Consulatants (P1 Trials -Exigent Network) | Houston, Texas, United States | Not Yet Recruiting |
| American Oncology Network Vista Oncology Division | Olympia, Washington, United States | Not Yet Recruiting |
| Northwest Medical Specialties PPLC (P1 Trials - Exigent Network ) | Tacoma, Washington, United States | Not Yet Recruiting |
+ 57 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07160335